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Abstract
Purpose There is renewed interest in the all-polyethylene
tibial component in total knee arthroplasty (TKA). Long-
term results of this prosthesis in rheumatoid arthritis (RA)
patients, however, are limited. Therefore, we studied 104
primary cemented all-polyethylene tibial TKA in 80
consecutive RA patients for up to 25 years to determine
the long-term survival of all-polyethylene tibial compo-
nents in patients suffering from end stage RA.
Methods We estimated revision rates according the revision
rate per 100 observed component years used in national
joint registries. Kaplan–Meier was used to estimate survival
curves.
Results During the 25-year follow-up, three revisions for
tibial component loosening were performed. The mean
revision rate of all-polyethylene tibial components with
revision for aseptic loosening as the endpoint was 0.09 per
100 observed component years. This corresponds to a
revision rate of 0.9% after ten years and 2.25% after
25 years. Survivorship according to Kaplan–Meier was
100% at ten years and 87.5% at 25 years [95% confidence
interval (CI) 64.6–100)].
Conclusion This study shows good long-term results of all-
polyethylene tibial TKA in patients with RA. RA patients
with multiple-joint inflammation may be less physically
active than osteoarthritis patients, resulting in a lower
demand on the prosthesis, and these patients may, indeed,
be good candidates for all-polyethylene tibial TKA. Our
results suggest that all-polyethylene tibial TKA could be a
successful and cost-saving treatment for end-stage knee
arthritis in RA patients.
Introduction
All-polyethylene tibial (APT) total knee arthroplasty (TKA)
has gained renewed interest [1]. An important concern is
the combination of durability with cost reduction compared
with metal-backed tibial (MBT) components. Implant costs
can decrease by 20–50% using APT components [1]. This
prosthesis is recommended for patients who are less
physically demanding [2]. RA patients in general are more
physically impaired compared with those suffering from
osteoarthritis (OA) patients. This is partially due to the
polyarticular involvement of the disease. TKA has proven to
be a successful surgical intervention that reduces pain and
enhances physical function of RA patients [3]. Additionally,
primary TKA is one of the most frequently performed
orthopaedic interventions in such patients [3]. One of the
first total knee prostheses with an APT design was the total
condylar knee prosthesis (Zimmer, Warsaw, IN, USA). This
prosthesis showed excellent clinical results at long-term
follow-up of mainly OA patients [4]. Over time, this implant
was modified to an MBT component because in vitro studies
indicated improved load distribution to the proximal tibia
[5, 6]. Despite biomechanical evidence, this has not been
demonstrated in clinical studies.
Department of Orthopaedics, Leiden University Medical Center,
Leiden, The Netherlands Universal Trial Number (UTN) U1111-1113-
6472; Dutch Trial Registry (NTR) TC 2218
K.-A. Nouta (*): B. G. Pijls:R. G. H. H. Nelissen
Department of Orthopaedics, Leiden University Medical Center,
Postzone J11R, P. O. Box 9600,
2300 RC, Leiden, the Netherlands
e-mail: K.A.Nouta@lumc.nl
B. G. Pijls
e-mail: B.G.C.W.Pijls@lumc.nl
R. G. H. H. Nelissen
e-mail: R.G.H.H.Nelissen@lumc.nl
International Orthopaedics (SICOT) (2012) 36:565–570
DOI 10.1007/s00264-011-1341-4Few studies have been performed on TKA with an APT
component in patients with rheumatoid arthropathy, as
identified with a search in the PubMed library using the
following key words: total knee arthroplasty, rheumatoid
arthritis, polyethylene and relevant abbreviations and
synonyms [7–9]. Therefore, long-term results of this type
of TKA in this specific population are scarce. Knowledge
of long-term outcomes is necessary to evaluate efficacy and
durability of joint replacements, especially in patients with
RA because of their relatively young age [10]. Therefore,
our aim was to determine the long-term survival (up to
25 years) of APT components in TKA in patients suffering
from end-stage RA.
Patients and methods
From 1979 to 1990, 104 primary cemented APT (ultra-
high-molecular-weight polyethylene) tibial TKA with the
semiconstrained cruciate-ligament-sacrificing total condylar
(type I) knee prosthesis (Zimmer) were performed in a
generalised academic institute in 80 consecutive patients
with RA. In 24 patients, bilateral TKA was performed. The
diagnosis of RAwas assessed by a rheumatologist using the
nomenclature and classification of arthritis and rheumatism
[11]. Previously, the four to ten year survival rate of some
of these patients and the basic operative technique were
described by the senior author [12]. The procedure is
performed through a standard midline skin incision and a
medial parapatellar arthrotomy. It includes measures for
proper patellar tracking, releases for fixed deformities,
balancing the tension in the medial and lateral collateral
ligaments and restoring the proper mechanical axis of the
lower extremity.
Data-collection procedure
The study was conducted after approval of the hospital
ethical committee (reference number P09.244). All patients
were followed up at predefined visits at our orthopaedic
department. We collected information regarding possible
failure of the prosthesis from the hospital database. We also
checked databases of the two nearest hospitals to rule out
possible revisions. In case of an incomplete follow-up, we
contacted the patient’s general practitioner (GP) to enquire
about revisions elsewhere or problems with the prosthesis.
In The Netherlands, GPs receive all medical correspon-
dence related to a particular patient and are the centre in the
medical network: e.g. a patient must be referred by a GP
when a consultation by a specialist is required. Therefore,
in the event of problems with the prosthesis or if a revision
was performed in another hospital, the GP will have the
record. Finally, we consulted the community registry to
check possible date of death of all patients to determine the
endpoint of follow-up. For 63 patients (81 TKAs), informa-
tion was collected until death or revision. After the 25-year
follow-up, revision in 17 patients (23 TKAs) could not be
ruled out with absolute certainty, and these patients were
nominated as being lost to follow-up (Figure 1). There were
no relevant differences between patients lost to follow-up
and other patients regarding demographics (Table 1).
Clinical evaluation of all patients was performed using
the Hospital for Special Surgery (HSS) knee scoring system
[13]. OfTKA instability atone yearfollow-up was examined.
Fig. 1 All patients during the
25-year follow-up. Two patients
are counted twice because they
underwent revision of one total
knee arthroplasty (TKA) and
died with the other TKA
unrevised
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moderate 5–15°, severe ≥15° [13]. Radiological evaluation,
including assessing alignment, radiolucent lines and possible
loosening was performed using the Knee Society TKA
radiographic evaluation and scoring system [14].
Statistical analysis
The primary endpoint was revision or removal of the tibial
component for aseptic loosening. The secondary endpoint
was revision or removal of the tibial component for any
reason. We calculated revision rates according to the
Australian Arthroplasty Register and a recent systematic
review using revisions per 100 observed component years
[15]. This method gives outcomes that are easier to than
using national joint registries. The traditional Kaplan–Meier
method is inappropriate because it overestimates the risk of
revision, especially when the incidence of competing risks
is high [16]. This risk is very likely in long-term follow-up
studies of joint replacements because there is a high
incidence of the competing risk of death. We included a
worst-case-scenario analysis (i.e. every patient lost to
follow-up was considered as a revision). This represents
the lowest possible survival rate. The revision rates were
compared with revision rates of annual reports in national
joint registries of several countries. Despite the fact that the
Kaplan–Meier method overestimates the risk of revision,
we also estimated survival curves according to the
Kaplan–Meier method to allow comparison with clinical
studies. Calculations and survival curves were performed
using the multi state (mstate) library in R version 2.12
[17].
Results
Follow-up for the 80 patients was up to 25 years, and mean
duration of follow-up until death or revision of the 63
patients was 11 (range 1–25) years. For the 17 patients
without complete follow-up, this period was ten (range one
to 21) years (Table 1). Mean revision rate of the APT
component with revision for aseptic loosening as endpoint
for the 25 year follow-up was 0.09 per 100 observed
component years. This corresponds to a revision rate of
0.9% after ten years and 2.25% after 25 years. Survivorship
according to Kaplan–Meier was 100% at ten years (n=47)
and 87.5% [(95% confidence interval (CI) 64.6–100%)] at
25 years (n=3) (Figure 2).
The mean revision rate with revision for any reason was
0.27 per 100 observed component years. This corresponds
to a revision rate of 2.7% after ten years and 6.75% after 25
years. Survivorship according to Kaplan–Meier is 98.9%
(95% CI: 96.7–100) at ten years (n=47) and 79.3% (95%
CI: 54.3–100%) at 25 years (n=3) (Fig. 3). When
radiological failures are included the mean revision rate
was 0.53 per 100 observed component years.
Clinical follow-up
Mean HSS was 76 [range 28–93, standard deviation (SD)
11.6] and mean range of motion (ROM) was 97° (range 50–
130, SD 16.2) at a follow-up of six (range 2–10, SD 3.0)
years. At one year follow-up, 93% of prostheses had no
Table 1 Parameters of all
patients
Range ( ); standard deviation [ ]
FU follow-up, BMI body mass
index, ROM range of motion
aDetermined on 89% of cases
Complete FU (n=63) Lost to FU (n=17) Total (n=80)
Follow-up (years) 11 (1–25) [7.8] 10 (1–21) [4.9] 11 (1–25) [7.3]
Age (at index operation) 66 (30–82) [9.8] 69 (53–78) [6.4] 67 (30–82) [9.3]
Female (%) 78 87 80
BMI 25 (19–35) [3.6] 26 (20–32) [3.0] 25 (19–35) [3.5]
Femorotibial alignment
a 175 (166–181) [3.1] 177 (173–186) [3.1] 176 (166–186) [3.1]
ROM at 1 year 95 (45–130) [15.3] 94 (50–140) [20.6] 95 (45–140) [16.5]
Fig. 2 Survivorship curve (black line) showing revision for aseptic
loosening of the all-polyethylene tibial (APT) component with 95%
confidence intervals (dotted lines)
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instability.
Radiological follow-up
Postoperative femorotibial alignment was 176° (range 168–
186, SD 3.1). Mean beta (tibial) joint-line angle was 88°
(range 80–94, SD 2.3). Mean sagittal tibial angle was 88°
(range 69–96, SD 4.1) A radiolucent line of 1 mm under the
tibial component was observed in 47.5% of patients in the
first ten postoperative years. In 5%, a radiolucent line of
2 mm was observed under the tibial component. During
follow-up, three TKAs in three patients showed radio-
graphic loosening (13.2, 18.3 and 19.8 years postopera-
tively). However, these patients did not undergo revision
surgery. One patient with radiographic loosening at
13.2 years postoperatively refused revision. The remaining
two patients did not undergo revision surgery because the
complaints were relatively mild and they suffered from
severe immobility caused by end stage RA that affected
multiple joints.
Worst-case scenario
Mean revision rate in the worst-case scenario for the APT
component with revision for any reason as endpoint was
2.4 per 100 observed component years. Revision rates of
primary TKA according to annual reports of several
national joint registries range from 0.71 to 2.51 [15]. The
revision rate in the worst-case scenario of our cohort was
within this range (Figure 4).
Complications
Three revisions for loosening were performed: one for
aseptic loosening (23 years postoperative). This patient
underwent complete revision. Perioperatively, only the
tibial component was found to be loose. There were large
bony deficits, so augmentations of the tibial and femoral
component were necessary. Nine years after this revision
procedure, the patient was still satisfied with the prosthesis.
One patient underwent revision for septic loosening due to
a Staphylococcus aureus infection (3.7 years postopera-
tively). This patient underwent prosthesis removal and had
six weeks of antibiotic therapy prior to TKA reimplanta-
tion. Twenty-five months after revision, the infection
recurred and an arthrodesis was performed. On the
contralateral side, this patient also had a TKA with an
APT component. Throughout the study period, there were
no complications with this prosthesis. Another patient
experienced septic loosening due to a coagulase-negative
S. aureus infection (20.8 years postoperative). No revision
TKA was performed for this patient due to multiple
comorbidities. There were no signs of infection at the
contralateral TKA, so it remained in situ.
Fig. 3 Survivorship curve (black line) showing revision for any
reason of the all-polyethylene tibial (APT) component with 95%
confidence intervals (dotted lines)
Fig. 4 Revision rates (endpoint
revision for any reason) of the
best- and worst-case scenarios
(all cases lost to follow-up are
considered as revision) of the
all-polyethylene tibial (APT)
component and revision rates
after total knee arthroplasty
(TKA) in six countries
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patellar components as a primary indication. There were
five traumatic fractures of the distal femur (5.2; 8.3; 11.3;
14.6; 17.8 years postoperatively), two traumatic patellar
fractures (0.3; 11.9 years postoperatively), one nontraumatic
patellar fracture (2.3 years postoperatively) and one above-
knee amputation for vascular complications (8.8 years post-
operatively). All fractures were treated conservatively with
plaster cast and immobilisation. Two patients with bilateral
TKA experienced a distal femur fracture on both sides at
different times. No patient with a periprosthetic fracture
underwent TKA revision. One patient died 11 days after
TKA due to gram-negative sepsis of unknown origin.
Discussion
As this study offers the longest follow-up for a single APT
component in RA, it provides greater insight into long-term
survival rates of APT TKA. The study shows good long-
term survival, and revision rates are comparable with TKA
revision rates as noted in several national joint registries
[15]. Previous reports of APT TKA in RA patients show
results comparable with our study. Kristensen and Laskin
showed survival rates ranging from 81% to 89% at the ten
yearfollow-up[8, 9]. Rodriquez reported a 91% survival rate
at 15 years, with endpoint as revision for any reason [7].
Our study has some limitations: First, some patients
were lost to follow-up. To account for these patients, we
included a worst-case scenario to give an absolute lower
limit of the revision rate. The worst-case scenario assumes
all patients lost to follow-up were revised. The revision rate
of the worst-case scenario lies in the range of revision rates
according several national joint registries, as illustrated in
Fig. 4 [15]. Despite thorough attempts to collect complete
follow-up of all patients, revision in some patients could
not be ruled out with absolute certainty. The most important
reason for this lack of information was the limited storage
time of medical files, which are destroyed ten years after
the patient has died. Consequently, medical information for
patients who died more than ten years prior to our study
was almost impossible to trace. We checked the community
registry to determine the end of study time of each patient
and found that many patients died during the follow-up. At
the time of analysis, information of the patients who died
not long after TKA could therefore not be retrieved. Of
these patients, we ruled out revision in our hospital and in
the two nearest hospitals by gathering information from
their databases. Additionally, that group was comparable
with the complete follow-up group regarding several patient
demographics, as seen in Table 1. A second limitation was
that the APT total condylar knee prosthesis used in this
study is no longer used in today’s orthopaedic practice. As
the modern polyethylene types are expected to be superior to
the APT in our study, the revision rate of a modern APT may
even be lower than the revision rate of the total condylar knee
prosthesis, which had an excellent long-term track record [4].
RA is a chronic inflammatory disease that leads to
varying degrees of functional impairment and disability [7].
Many RA patients still require total joint arthroplasty
despite improvements in pharmacological treatment [3].
Functional status after TKA is inferior to that of OA
patients treated with TKA [7]. A reason is the polyarticular
involvement and the declining functional status due to the
disease. In the literature, patients who are relatively
sedentary and less active are classified as low demand, are
frequently elderly (>70–75 years old) or have RA [2, 7].
Low-demand patients generally place lower stress on their
TKA and thus reduce the wear rate and risk of revision.
According to the literature, APT TKA can be an acceptable
treatment for such low-demand patients and a cost-saving
treatment option [2, 18]. Many studies have compared APT
with MBT TKA. These studies investigated possible
superiority of MBT components. None of these studies
showed significant differences in favour of MBT TKA [18–
24]. In addition, a meta-analysis favours the use of a
nonstabilised APT component over an MBT component
[25]. Although all these studies show good results for APT
designs, one study showed high revision rates of one
specific APT design with low conformity [26]. This study
mainly reviewed OA patients (93%); our study, on the other
hand, reviews RA patients. Additionally, the design of this
tibial component differs from the APT design of the total
condylar prosthesis by conformity of the prosthesis be-
tween the femoral and tibial components. The APT design
of the total condylar has a higher conformity. In conclusion,
our results suggest that APT TKA could be a successful and
cost-saving treatment for end-stage knee arthritis in
rheumatoid patients.
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